Celeste Napier to Oxidopamine
This is a "connection" page, showing publications Celeste Napier has written about Oxidopamine.
Connection Strength
0.450
-
Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2016 10 03; 70:77-84.
Score: 0.144
-
Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson's disease and controls. Neuropsychopharmacology. 2012 May; 37(6):1397-408.
Score: 0.106
-
Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions. Brain Struct Funct. 2008 Sep; 213(1-2):197-213.
Score: 0.084
-
Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function. Exp Neurol. 2004 Apr; 186(2):145-57.
Score: 0.062
-
Alterations in responses of ventral pallidal neurons to excitatory amino acids after long-term dopamine depletion. J Pharmacol Exp Ther. 2002 Apr; 301(1):371-81.
Score: 0.054